Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/28255
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHolmes P.W.en
dc.contributor.authorKing P.T.en
dc.date.accessioned2021-05-14T09:30:53Zen
dc.date.available2021-05-14T09:30:53Zen
dc.date.copyright2012en
dc.date.created20120301en
dc.date.issued2012-03-01en
dc.identifier.citationReviews on Recent Clinical Trials. 7 (1) (pp 24-30), 2012. Date of Publication: February 2012.en
dc.identifier.issn1574-8871en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/28255en
dc.description.abstractBronchiectasis is defined by the presence of abnormal bronchial widening and occurs as a consequence of chronic airway infection. It is an important and common cause of respiratory disease. Antibiotics are the main therapy used for the treatment of this condition. The article will review the use of antibiotics for the treatment of bronchiectasis. Antibiotics can be given as short-term therapy for exacerbations or as long-term/maintenance therapy. Antibiotics given by the inhalational route and macrolides are two relatively new classes of medication that may be useful for long-term therapy. There are significant concerns about the overuse resulting in antibiotic resistance. It should be emphasized that nearly all of the trials in the literature have only had small numbers of subjects. The data that is available describing the use of antibiotics in bronchiectasis can generally be regarded as preliminary. © 2011 Bentham Science Publishers.en
dc.languageenen
dc.languageEnglishen
dc.publisherBentham Science Publishers B.V. (P.O. Box 294, Bussum 1400 AG, Netherlands)en
dc.titleUse of antibiotics in bronchiectasis.en
dc.typeReviewen
dc.type.studyortrialReview article (e.g. literature review, narrative review)-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.2174/157488712799363280en
dc.publisher.placeNetherlandsen
dc.identifier.pubmedid22023177 [http://www.ncbi.nlm.nih.gov/pubmed/?term=22023177]en
dc.identifier.source364311359en
dc.identifier.institution(King, Holmes) Department of Respiratory/Sleep Medicine, Monash Medical Centre Clayton, 246 Clayton Rd, Clayton, Melbourne 3168, Australia (King) Monash University, Department of Medicine, Monash Medical Centre, Melbourne, Australiaen
dc.description.addressP. T. King, Department of Respiratory/Sleep Medicine, Monash Medical Centre Clayton, 246 Clayton Rd, Clayton, Melbourne 3168, Australia. E-mail: paul.king@monash.edu.auen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2013 Elsevier B.V., All rights reserved.en
dc.subect.keywordsAntibiotic Resistance Bronchiectasis Inhalational Lung Macrolideen
dc.identifier.authoremailKing P.T.; paul.king@monash.edu.auen
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeReview-
Appears in Collections:Articles
Show simple item record

Page view(s)

2
checked on Feb 6, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.